RT Journal Article
SR Electronic
T1 <strong>Everything Radiologists Need to Know about Radioiodine: </strong><strong> The Royal Radiopharmaceutical for Diagnosis and Therapy of Thyrotoxicosis</strong>
JF Journal of Nuclear Medicine
JO J Nucl Med
FD Society of Nuclear Medicine
SP 988
OP 988
VO 58
IS supplement 1
A1 Kinner, Jeffrey
A1 Oates, M.
A1 El Khouli, Riham
YR 2017
UL http://jnm.snmjournals.org/content/58/supplement_1/988.abstract
AB 988Objectives: 1. Explain how the properties of the common radioiodines make them the ideal radiopharmaceuticals for thyroid uptake and imaging (123I) and therapy (131I). 2. Review the role and application of 123INa in the work-up of thyrotoxicosis. 3. Review the role and application of 131INa in the non-invasive therapy of hyperthyroidism.Methods: This will be an image-rich, case-based review of the role of the common radioiodines (123INa, 131INa) used in the diagnosis and therapy of patients with thyrotoxicosis/hyperthyroidism. Disorders include Graves’ disease, toxic multinodular goiter, autonomous toxic nodules, and subacute thyroiditis. The 131INa therapeutic dosages and radiation safety guidelines will be reviewed. Results: NAConclusion: Learners will gain an understanding of the characteristics that make the radioiodines perfectly suited for evaluation and therapy of thyrotoxicosis/hyperthyroidism. After reviewing this exhibit, they will be better prepared to integrate functional uptake values with morphologic pinhole images across the spectrum of toxic disorders of the thyroid gland. Learners will understand how to prescribe appropriate therapeutic 131INa dosages. Research Support: NA